[1]
L. Chen, N. Zhou, and L. Zhang, “Efficacy and Safety of Canagliflozin in STEMI Patients with Type 2 Diabetes after PCI: A Retrospective Study”, HSF, vol. 27, no. 8, pp. E898-E906, Aug. 2024.